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Abstract
Aims and objective: To explore the experience of adult patients and adult patients’ 
families, and their perception of the support systems received during the diagnostic 
process of rare diseases.
Background: There are about 7,000 rare diseases that affect 7% of the world's pop-
ulation. Rare diseases are often underdiagnosed. This has been reported to have 
deleterious physical and psychological consequences in both the patients and their 
families, especially when institutional support during this process is low.
Design: A scoping review was carried out following the 6- phase model proposed by 
Arksey & O’Malley and Levac et al., including the consultation phase in which pa-
tients diagnosed with rare diseases were interviewed to seek their views on the bib-
liographic evidence reviewed and their experience during the diagnostic process.
Methods: The databases consulted were PubMed, CINAHL, Web of Science, SCOPUS, 
Cochrane Library, PsycINFO, OpenGrey, ProQuest Dissertations and Theses Global. 
They were explored from inception– July 2020, and qualitative, quantitative and 
mixed method studies were included. The Mixed Methods Appraisal Tool was used 
for the critical evaluation of the articles. The review was based on the guidance in the 
PRISMA- ScR statement.
Results: The initial search identified 2,350 articles, of which 20 fully met the inclusion 
criteria and were therefore reviewed. In this analysis appeared two dimensions: inter-
nal factors: emotional aspects, and external factors: resources and support systems.
Relevance to clinical: This review provides evidence on the emotional impact of the 
diagnostic process and during the communication phase of the definitive diagnosis. 
Health systems and professionals must be strengthened in order to improve the infor-
mation, training and resources. Nurses can play a key role in coordinating communica-
tion and follow- up of those affected.
K E Y W O R D S
diagnostic, emotional, experiences, rare disease, support system
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1  |  INTRODUC TION
Rare diseases (RDs) are defined as those that have a low prevalence 
in the population. To qualify as rare, each specific disease can only 
affect less than 5 in 10,000 inhabitants (Aymé et al., 2008; Bogart & 
Irvin, 2017) such as myelofibrosis with a prevalence of 2,7: 100.000 
individuals (Alarcón- Ovalle et al., 2016) or primary ciliary dyskinesia 
whose reported prevalence varies from 1: 2000– 1: 40000 (Behan 
et al., 2016) and Hermansky– Pudlak syndrome with a prevalence of 
1: 500.000 a 1: 1.000.000 in non- Hispanic people and 1: 18.00 in 
Hispanic people (Christensen et al., 2017).
Despite the differences in the aetiology and symptoms of RDs, 
many of them are chronic, involve multisystemic dysfunction, are 
not effectively treated and require complex care (Aymé et al., 2008). 
Due to the small amount of people affected by each individual RD, 
funding for research into causes and treatments is limited, which 
slows down the discovery of diagnostic tools and potential therapies 
(Grigull et al., 2019).
There are also psychological consequences, the name itself indi-
cates it, "rare disease" and that is why many people who suffer from 
it feel out of the ordinary (Blöß et al., 2017). As a result, they feel 
discriminated at a social level in aspects such as leisure, education or 
even daily life activities (Alarcón- Ovalle et al., 2016). Affected peo-
ple need help with daily activities and often lack the resources to 
address these needs (Budych et al., 2012).
The diagnosis of an RD helps facilitate access to effective medi-
cal, psychological and social care and treatment (Aymé et al., 2008). 
Getting the right diagnosis, even when there is no treatment, in-
creases people's opportunities to plan for their future (Khosla & 
Valdez, 2018). The moment of diagnosis is a painful experience in 
most cases (Bogart & Irvin, 2017). Being diagnosed with an RD is a 
long road, and the urgency of the patient and their family members 
does not always coincide with the speed observed by professionals 
or the health system (Heuyer et al., 2017). The process is called the 
diagnostic journey which starts when patients first go to a health-
care provider to consult their symptoms and ends when they receive 
the correct diagnosis. This journey is fraught with great emotional 
and physical baggage (Geng et al., 2019).
In this process, the lack of information about RDs, the lack of co-
ordination between health professionals, the lack of specialists with 
clinical experience and the poor functioning of the health services 
affect both the person and his/her family negatively from the first 
moment (Crowe et al., 2019). Jaeger et al., (2015) showed in their 
study that people with RDs are isolated and most of the population 
lacks awareness about them, resulting in their being misunderstood, 
avoided and blamed. Consequently, social and environmental barriers 
limit the ability to participate in social roles and activities (Bogart & 
Irvin, 2017). Similarly, the psychological and emotional reactions as-
sociated with the diagnosis can negatively influence the process of 
adaptation to the disease and the quality of life (Castillo- Esparcia & 
López- Villafranca, 2016). In reality, these emotions are the adjustment 
to a multi- component process that generates a response to the adap-
tive challenges of a particular situation (Nesse & Ellsworth, 2009).
This study has focused on the diagnostic process, that is on the 
two initial phases described by Schwartz (2009), which both the 
person and his/her family environment go through. There are 5 
phases: (a) uncertainty and confusion due to the appearance of the 
first symptoms; (b) confusion at the time the diagnosis is received; (c) 
opposition and isolation, as well as cushioning to maintain hope and 
to be able to fit the new reality; (d) anger and sadness; and finally 
(v) phase of adaptation. For the people affected and their families, 
going through these phases has emotional implications generated by 
stressful life circumstances. Additionally, due to the low prevalence 
of the different RDs studied individually there is a lack of knowledge 
and holistic perspective of service providers (Budych et al., 2012). 
These systems are classified as inadequate to respond to the needs 
of patients, and this inadequacy leads to unpleasant experiences.
Finally, it should be noted that there is a lack of literature reviews 
that explore the psychological theme. After reviewing the literature, 
we found the study by von der Lippe et al., (2017) which addresses 
the psychosocial experience of adults who share a diagnosis of a rare 
disease through a systematic review. However, there are no reviews 
that focus exclusively on the pre- diagnosis phase and the time of 
diagnosis. Knowing the emotional experience (affected persons and 
family members) in these two phases through the detailed overview 
provided by a scoping review can undoubtedly help to achieve a bet-
ter adaptation of those affected in these and subsequent stages.
2  |  AIMS
This scoping review aims to explore, according to published evi-
dence, the emotional experience of adults with an RD and their 
families during the diagnostic process and their perception of the 
What does this paper contribute to the wider?
• There is a deficit of care for those affected, as opposed 
to chronic diseases that are not rare; therefore, there is 
a need for multidisciplinary support; but in the case of 
RD, the professionals who would have to provide this 
support also have relevant deficiencies that must be 
addressed.
• The emotional aspects that have emerged require 
the development of basic strategies such as patient– 
professional communication and trust, as well as large- 
scale research and early diagnosis strategies, especially 
those that minimise the impact of socio- demographic 
and gender aspects that act as health determinants in 
RD.
• Interventions and studies in the field of RD nursing are 
essential, as is the need to strengthen the professional 
role in the training and care of individuals and families 
affected by RD.
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support activities received to meet their health, care or daily life 
needs.
3  |  METHODS
3.1  |  Study design
This scoping review used the Arksey and O’Malley (2005) frame-
work. Subsequently, other authors (Levac et al., 2010) proposed 
supplementary considerations to the review model, adding a 
more complete explanation of each of the six stages of the pro-
cess. The scoping review followed the Preferred Reporting Items 
for Systematic Review and Meta- Analyses extension for Scoping 
Review (PRISMA- ScR) checklist (File S1).
3.2  |  Stage 1: identifying the research question
Based on Levac et al. (2010), research questions should consider jus-
tification and clarify purposes. To this end, it was agreed that the 
following questions should be asked:
• How do adults with an RD and/or their families describe their ex-
periences during the diagnostic process?
• What is the perception of adults with an RD and/or their fami-
lies about the support activities they were provided with to meet 
their care needs during the diagnostic process?
3.3  |  Stage 2: identifying relevant studies
The databases consulted for the identification of studies were 
PubMed, CINAHL, Web of Science, SCOPUS, Cochrane Library and 
PsycINFO, and for grey literature, Google, Google Scholar, OpenGrey 
and ProQuest Dissertations and Theses Global. A manual review of 
article references was conducted as an additional data source.
A comprehensive search strategy was developed by an informa-
tion specialist (see File S2 for search strategy). The appropriate key-
words were selected for each database, using MeSH or free terms: 
Diagnosis, Experiences, Rare Disease and Support System, among 
others, as well as Boolean operators for maximum sensitivity and 
specificity.
Eligibility criteria included the following: (a) studies of any type 
of RD (qualitative, quantitative and mixed method studies) were sys-
tematically searched from inception– 31 July 2020; (b) study popula-
tion: adults (16+) with an RD diagnosis, family members and experts 
(healthcare professionals); (c) articles related to the experience of 
the disease from the patient and/or family perspective; (iv) articles 
focusing on psychosocial and support care, access to services, qual-
ity of care, experiences, daily activities and consequences of delayed 
diagnosis; and (v) publications in English, Spanish, Italian, French and 
Portuguese. Exclusion criteria included the following: (a) articles 
funded by commercial interests and (b) review studies of the litera-
ture, letters, conference papers or similar primary documents.
3.4  |  Stage 3: study selection
The selection process was carried out using the Covidence tool 
(https://www.covid ence.org/). This tool is web- based software 
used to do primary screening, data extraction and synthesise. This 
process was carried out by two independent reviewers (LL and AT). 
Any differences were resolved by a third reviewer (JR). This third 
reviewer examined 10% of the abstracts for eligibility criteria.
Following the guidelines of Levac et al. (2010), the rest of the 
research team met at the initial, intermediate and final stages of 
the review process to resolve any uncertainties related to the 
selection of studies. Though is not mandatory in a scoping re-
view (Arksey & O’Malley, 2005), a decision was made to assess 
methodological quality using the Mixed Methods Appraisal Tool 
(MMAT)— 2018 Version. The choice of this tool was based on the 
fact that it includes all types of methodological studies (quantita-
tive, qualitative and mixed).
3.5  |  Stage 4: charting the data
A standardised, pre- piloted form was used to extract data from the 
included studies. The following information was extracted: (a) au-
thor; (b) year of publication; (c) language; (iv) country of study; (v) 
characteristics of the population studied; (vi) quality of the study; 
(vii) purpose of the study; and (viii) main results.
One review author extracted the data (LL), and this was cross- 
checked by another member of the review team.
3.6  |  Stage 5: collating, summarising and 
reporting the results
The included manuscripts were manually coded into themes, which 
were grouped into the following dimensions: (a) internal factors: 
emotional aspects and (b) external factors: resources and support 
systems.
3.7  |  Stage 6: consultation
This consultation stage is optional. Interviews with patients with 
RD were organised through the Spanish Federation of Rare Disease 
that included the profiles of adults with a diagnosis no older than 
10 years. This period was considered for the proximity to the diag-
nostic event, and to ensure the confirmability of the information. 
The interviews addressed the pre- diagnosis experience and the ex-
perience at the time of diagnosis based on aspects such as (a) per-
sonal, family and social experience; and (b) resources and support 
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used or available. This phase was used to validate the results of the 
review (Arksey & O’Malley, 2005; Levac et al., 2010).
3.8  |  Ethical aspects
Given the incorporation of phase 6 in the review, the Clinical 
Research Ethics Committee of the Hospital Universitari Arnau de 
Vilanova de Lleida (Spain) was consulted. The issued resolution 
stated that, given the nature of the study, it did not require their 
approval.
The participants in the consultation phase signed the informed 
consent to participate in the project. Data confidentiality and ano-
nymity was ensured throughout the process by assigning an alpha- 
numeric code to each interview. All participants had the opportunity 
to review the content of their interviews and make comments.
4  |  RESULTS
4.1  |  Study selection
The initial search identified a total of 2,350 articles. Applying 
the inclusion and exclusion criteria, indicated in stage 2 of the 
scoping review methodology, the number of studies was re-
duced to 1,214. Subsequently, screening of titles/abstracts was 
used and 161 remained for full text selection. Specifically, of the 
141 studies, 88 were found to be inappropriate, 46 were on the 
wrong subject and in 7 the language was not in the inclusion cri-
teria. Finally, 20 articles were considered eligible for inclusion in 
the data extraction.
Likewise, in the concordance analysis between evaluators, 97% 
(p1) of coincidences were observed as opposed to the 85% (pe) ex-
pected by chance, in this case p1 > pe, so we found more concor-
dance than was expected by chance, placing it at a Cohen kappa 
index of 0.810. This evaluation was almost perfect.
The flow of literature though the study is shown in Figure 1.
4.2  |  Description of included studies
The results in relation to the description of the studies are organised 
in two points: characteristics of the included studies and quality of 
the evidence of the studies. The main characteristics of the studies 
are shown in File S3.
4.2.1  |  Study characteristics
The studies were carried out in countries on different continents, 
especially in Europe (Germany, Denmark, Spain, Italy, Portugal and 
the UK) 50% (n = 10), followed by America (Brazil, Canada, Colombia 
and the US) 35% (n = 7), then Oceania (Australia) 10% (n = 2) and 
finally Asia (China) with 5% (n = 1).
F I G U R E  1  PRISMA diagram
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The subjects included in the research had different roles in rela-
tion to the RD, that is patients, relatives and/or professionals. Of the 
twenty studies, four of them, or 20%, showed evidence focused only 
on patients diagnosed with an RD (Adams et al., 2018; Alarcón- Ovalle 
et al., 2016; Christensen et al., 2017; Jensen et al., 2019), and 45%, 
nine studies of the total, reported only on relatives (Anderson et al., 
2013; Bendixen & Houtrow, 2017; Cardinali et al., 2019; Custódio 
et al., 2018; Esteban et al., 2015; Germeni et al., 2018; Granero- 
Molina et al., 2020; Lim et al., 2012; Zurynski et al., 2017). Then, 
four studies focused on both family members and patients with an 
RD, representing 20% (Behan et al., 2016; Esquivel- Sada & Nguyen, 
2018; Henderson et al., 2009; Requena et al., 2014), whereas only 
one study focused on RD experts (Blöß et al., 2017). One included 
patients, relatives and lawyers (Kesselheim et al., 2015), and one in-
cluded patients, relatives, organisations and healthcare professionals 
related to RDs which represent 5% each (Lopes et al., 2018). From this 
description, we can see that 75% of the articles studied the relatives, 
50% included the affected people, and only 10% considered the pro-
fessionals or associations that offer care to people with an RD.
The total number of participants was 1568, men (81.7%) and 
women (n = 18.3%). The age of the participants with an RD was 
16 years minimum and 80 years maximum.
Some of the studies (Blöß et al., 2017; Cardinali et al., 2019; 
Esquivel- Sada & Nguyen, 2018; Kesselheim et al., 2015; Lopes et al., 
2018; Requena et al., 2014; Zurynski et al., 2017) refer to RD pa-
thologies in general, although others detail the pathologies such as 
lipodystrophy (Adams et al., 2018), myelofibrosis (Alarcón- Ovalle 
et al., 2016), lysosomal storage disease and mitochondrial disease 
(Anderson et al., 2013), primary ciliary dyskinesia (Behan et al., 
2016), duchenne muscular dystrophy (Bendixen & Houtrow, 2017), 
Hermansky– Pudlak syndrome (Christensen et al., 2017), Wolfram's 
syndrome (Esteban et al., 2015), Bartter syndrome (Germeni 
et al., 2018), hereditary angioedema (Granero- Molina et al., 2020), 
Niemann– Pick disease type B (Henderson et al., 2009), mastocytosis 
(Jensen et al., 2019), Rett syndrome (Lim et al., 2012) and osteogen-
esis imperfecta type 1 (Custódio et al., 2018).
The level of education is only mentioned in 6 studies (Cardinali 
et al., 2019; Christensen et al., 2017; Esquivel- Sada & Nguyen, 2018; 
Germeni et al., 2018; Henderson et al., 2009; Lim et al., 2012). Three 
studies (Alarcón- Ovalle et al., 2016; Cardinali et al., 2019; Henderson 
et al., 2009) included assessment of the socio- economic conditions 
of the participants, detailing the different economic strata (high, me-
dium and low) and total yearly income.
The ethnicity of the participants is only collected in the study 
by Anderson et al. (2013). Likewise, the articles do not refer to the 
cultural aspects of the participants. In the study by Henderson et al. 
(2009), they do value religion.
4.2.2  |  Methodological quality
The review comprises 20 studies of qualitative methodology (75%), 
quantitative methodology (10%) and mixed methods (15%). All were 
critically evaluated according to the MMAT tool. These judgements 
are presented in File S4. In the following section, methodological 
quality is summarised narratively based on the study design.
Qualitative studies (n = 14) (Lim et al., 2012; Requena et al., 
2014; Kesselheim et al., 2015; Alarcón- Ovalle et al., 2016; Bendixen 
& Houtrow, 2017; Blöß et al., 2017; Christensen et al., 2017; Adams 
et al., 2018; Lopes et al., 2018; Esquivel- Sada & Nguyen, 2018; 
Germeni et al., 2018; Cardinali et al., 2019; Jensen et al., 2019; 
Granero- Molina et al., 2020). All studies were judged to have ap-
propriately used the qualitative approach to answer the research 
question and to have adequately used the qualitative data collec-
tion methods to address the research question. One study (Requena 
et al., 2014) does not specify the data analysis used. The interpreta-
tion of results of one study (Alarcón- Ovalle et al., 2016) is not sup-
ported by the data collected. All studies show clear links between 
data sources, collection, analysis and interpretation.
Quantitative descriptive studies (n = 2) (Anderson et al., 2013; 
Zurynski et al., 2017). These studies were judged to be employing a 
relevant sampling strategy and appeared to have used appropriate 
measurements. However, the study (Anderson et al., 2013) judged 
that the sample was not regarded to be representative of the target 
population. One study (Zurynski et al., 2017) was judged as low risk 
of nonresponse bias. Both studies show clearly established and jus-
tified statistical analysis.
Mixed methods studies (n = 4) (Behan et al.,l., 2016; Custódio 
et al., 2018; Esteban et al., 2015; Henderson et al., 2009). All studies 
show adequate justification for using a mixed method design and 
effectively integrate study components to address the research 
question. The four studies do not show divergences or inconsisten-
cies when integrating the findings of the qualitative and quantitative 
components. However, one study (Esteban et al., 2015) does not ex-
plain how the data were extracted from the qualitative component.
4.3  |  Experiences and perceptions of 
patients and families
This review showed findings about the diagnostic care process expe-
rienced and perceived by people affected by RD and their families. 
The dimensions explored were internal factors (personal aspects 
of the experience and impact of the diagnosis) and external factors 
(resources and support systems). In this sense, a series of themes 
emerged which allowed us to detail the origin and nature of the 
emotional reactions throughout the diagnostic process. In Figure 2, 
a scheme of findings is shown.
4.3.1  |  Internal factors: Emotional aspects
Emotions linked to the lack of diagnosis
Emotions linked to the lack of diagnosis were sometimes shown as 
feelings of abandonment or contempt, when they were not taken 
into account or taken seriously (Behan et al., 2016; Esquivel- Sada 
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& Nguyen, 2018; Kesselheim et al., 2015); experiences doubly re-
ported by patients and their families (Bendixen & Houtrow, 2017; 
Zurynski et al., 2017). They related this shared process (person- 
environment) and this multidimensional experience of psychological, 
social and physical discomfort.
There was even a relationship between stress and information: 
the more stress, the more pressing the need to know (Germeni 
et al.,l., 2018). Families also reported feelings of guilt about the lack 
of a diagnosis (Granero- Molina et al., 2020) or the fear of not feeling 
competent to care for their child (Custódio et al., 2018).
Emotions linked to the passage of time and lack of control
Emotions linked to the passage of time and lack of control were 
associated with undiagnosed disease progression and fear of 
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negative health impacts due to delay in diagnosis (Behan et al., 2016; 
Christensen et al., 2017; Granero- Molina et al., 2020; Kesselheim 
et al., 2015; Zurynski et al., 2017).
Emotions linked to instrumental or procedural aspects
Emotions linked to instrumental or procedural aspects were linked 
to the need to live through years of examinations and difficulties, 
transfers, hospitalisations, surgery or various treatments (Alarcón- 
Ovalle et al., 2016; Germeni et al., 2018; Granero- Molina et al., 
2020; Lim et al., 2012), as well as receiving misdiagnosis and unnec-
essary treatment (Behan et al., 2016; Kesselheim et al., 2015). As 
described above, the study by Blöß et al. (2017) detailed that RD pa-
tients shared pre- diagnostic phenomena that included a high degree 
of frustration. That is, common experiences that included a feeling 
of disappointment and being incorrectly labelled as having psycho-
logical problems or being hypochondriacal (Jensen et al., 2019). 
Requena et al., (2014) described it as a negative circular process of 
stagnation and pilgrimage in the search for a diagnosis. Sometimes, 
alternative methods were used without any scientific basis because 
of desperation in the search for answers (Germeni et al., 2018).
The lack of therapeutic communication in the absence of a di-
agnosis was an exhausting process, on a psychological, social and 
even health professional level, which lead to a great deal of misun-
derstanding for the individual and his/her family (Granero- Molina 
et al., 2020). Sometimes, the doctors did not accept the complaints 
and/or these were misinterpreted (Blöß et al., 2017) and even con-
frontations occurred (Requena et al., 2014).
Emotions linked to the symptomatology
Emotions linked to the symptomatology according to the pathology. 
These signs and symptoms were diverse due to the large number 
of diseases and their characteristics. The disease was unpredictable 
and difficult to control (Jensen et al., 2019). As an example, in the 
study by Custódio et al. (2018) the threat of pain from fractures was 
continuous or in the study by Adams et al. (2018) on lipodystrophy 
due to physical changes, female participants described an impact 
on their femininity; they felt inferior because they did not meet 
the expectations of how a woman should be. This discomfort with 
their bodies leads to negative feelings about sexuality (Jensen et al., 
2019).
They also referred to changes in aspects of daily life such as eat-
ing, sleeping, working and physical activity (Alarcón- Ovalle et al., 
2016; Henderson et al., 2009; Lopes et al., 2018). Sometimes, suf-
fering from RD leads to isolation and social stigma due to rejection 
(Granero- Molina et al., 2020; Henderson et al., 2009; Lopes et al., 
2018), a situation that was exacerbated in women (Jensen et al., 
2019). These derived emotional aspects such as frustration and 
self- doubt went completely unnoticed by health professionals (Blöß 
et al., 2017) as they focused more on physical symptoms.
Emotions linked to the moment of diagnosis appear in studies
Emotions linked to the moment of diagnosis appear in studies (Adams 
et al., 2018; Behan et al., 2016; Christensen et al., 2017; Germeni 
et al., 2018; Granero- Molina et al., 2020; Jensen et al., 2019; Lopes 
et al., 2018) where they related the relief of diagnosis as a source of 
explanation for their medical problems, but also of the generation of 
negative feelings such as anxiety, stress, sadness, anger, fear, guilt, 
disbelief, denial, avoidance or concealment (Alarcón- Ovalle et al., 
2016; Esquivel- Sada & Nguyen, 2018; Esteban et al., 2015; Zurynski 
et al., 2017). Thus, the impact of the diagnosis was multiple since it 
influenced at a personal and social level (Esquivel- Sada & Nguyen, 
2018). Patients highlighted the ambivalent feelings at the beginning, 
and later, the relief.
This process was shared in other studies (Adams et al., 2018; 
Germeni et al., 2018; Granero- Molina et al., 2020; Jensen et al., 
2019; Lopes et al., 2018), which referred to being diagnosed as 
creating trust, meaning, order, adaptation and security in a chaotic 
number of symptoms for patients and families, in addition to the se-
curity of being able to follow adequate treatment and gaining ac-
cess to different specialists (Esquivel- Sada & Nguyen, 2018) and to 
stop feeling misunderstood, intimidated and stigmatised (Granero- 
Molina et al., 2020).
The people affected and their families remembered the moment 
of the diagnosis in detail; the space, the verbal and non- verbal com-
munication, and the emotions experienced. Without a doubt, the 
moment of diagnosis was a time of tension for everyone involved 
as an RD implies a infrequent and chronic disease which can some-
times be degenerative and without available treatment (Requena 
et al., 2014).
It is also important to note that a diagnosis of a genetic disease 
could lead to family conflicts (such as the difficulty of sharing the 
diagnosis with other members for fear of repercussions or discrimi-
nation because of an affected family lineage), and at the same time, 
it was shown to be an aid to life planning and reproductive decision- 
making (Esquivel- Sada & Nguyen, 2018; Esteban et al., 2015).
4.3.2  |  External factors: Resources and 
support systems
Two themes emerged from the external factors: facilitating ele-
ments and barriers.
Facilitators
Facilitators, according to the study by Granero- Molina et al. (2020), 
were channelled through the establishment of support groups and 
the provision of appropriate information; these maximised emo-
tional, social and instrumental support. Patients confirmed support 
from family, support groups, specialised associations (Anderson 
et al., 2013; Germeni et al., 2018; Zurynski et al., 2017) and spiritual 
support groups (Alarcón- Ovalle et al., 2016; Christensen et al., 2017). 
They also highlighted the benefits of sharing experiences with peer 
groups, in social networks or in face- to- face meetings (Adams et al., 
2018; Christensen et al., 2017; Esquivel- Sada & Nguyen, 2018).
Other elements such as the need for financial support and 
health services with a multidisciplinary character (doctors, nurses, 
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psychologists, social workers and/or case managers) (Anderson 
et al., 2013; Zurynski et al., 2017) were also mentioned. In the study 
by Granero- Molina et al. (2020), the role of community nurses was 
highlighted. They were able to help to improve knowledge and train 
patients and families in drug administration and different care needs.
At the time of diagnosis, it was essential to balance the infor-
mation being supplied (Requena et al., 2014). Families shared this 
aspect, and therefore, the need for adequate information and train-
ing enabled them to provide care (Custódio et al., 2018). This helped 
a two- tier accommodation process to take place: from the point 
of view of content and of the emotions generated (Requena et al., 
2014).
Finally, and a very relevant facilitator to be promoted, was the 
collaborative and proactive attitude of people with an RD (Requena 
et al., 2014).
Barriers
Barriers were defined as those aspects that hindered the process 
or needed to be improved given their relevance to the diagnostic 
process. A very important element was the need to improve com-
munication between patient and health professional (Requena et al., 
2014, Bendixen & Houtrow, 2017, Custódio et al., 2018, Esquivel- 
Sada & Nguyen, 2018, Cardinali et al., 2019). On the other hand, 
the people affected put forward the need for a more global vision 
among specialists.
This aspect of the need for multidisciplinary and coordinated 
comprehensive care from the outset was reported by other stud-
ies (Bendixen & Houtrow, 2017; Lopes et al., 2018; Zurynski et al., 
2017). Lack of guidance during diagnosis broke the trust between 
healthcare personnel, patients and families (Bendixen & Houtrow, 
2017; Cardinali et al., 2019).
As a key element, the limited knowledge of doctors (Adams et al., 
2018; Anderson et al., 2013; Cardinali et al., 2019; Henderson et al., 
2009; Kesselheim et al., 2015; Lim et al., 2012; Lopes et al., 2018; 
Zurynski et al., 2017) and nurses (Lopes et al., 2018) should have 
been noted. Therefore, it was essential to promote training in RDs 
at the undergraduate, postgraduate and continuing education levels 
(Anderson et al., 2013). This lack of knowledge and training meant 
that existing evidence- based diagnostic standards and clinical guide-
lines for some pathologies were not applied (Bendixen & Houtrow, 
2017). Even in the study by Christensen et al. (2017), participants 
narrated their role as experts and the need they felt to educate pro-
fessionals, in a role reversal. This element was also made explicit in 
other studies (Kesselheim et al., 2015).
Other barriers included inadequate and insufficient resources 
(Germeni et al., 2018; Granero- Molina et al., 2020; Henderson et al., 
2009), the presence of experts in tertiary centres and not in the 
community (Kesselheim et al., 2015) which forced long waits and 
very long journeys (Lim et al., 2012), the difficulty of diagnosing 
diseases not included in screening and the lack of warning systems 
(Blöß et al., 2017), the restriction of genetic testing (Lim et al., 2012), 
the attitude of doctors (Behan et al., 2016; Lim et al., 2012; Zurynski 
et al., 2017), the need for more psychological support (Adams et al., 
2018; Anderson et al., 2013; Henderson et al., 2009), the lack of 
coordination (Anderson et al., 2013; Esquivel- Sada & Nguyen, 2018; 
Lopes et al., 2018), research (Anderson et al., 2013; Behan et al., 
2016; Christensen et al., 2017), financial support (Anderson et al., 
2013; Lopes et al., 2018; Zurynski et al., 2017) or other support sys-
tems (Custódio et al., 2018; Germeni et al., 2018; Granero- Molina 
et al., 2020).
Finally, two relevant aspects should have been detailed. On the 
one hand, the obstacles for the diagnostic process and its conse-
quences affected not only patients and families but also health pro-
fessionals (Requena et al., 2014, Lopes et al., 2018). On the other 
hand, the health system of a country and the type of coverage it of-
fers (through public financing or private insurance) established clear 
differences in health care (Esquivel- Sada & Nguyen, 2018).
4.4  |  Stakeholder Consultation
Finally, 4 interviews were conducted with people affected by RD. 
The interviews were conducted by telephone due to the limitations 
of the COVID- 19 situation and the territorial dispersion of the people. 
The main results of the interviews validate the data obtained in the 
review: (a) the diagnostic process as very long and distressing with 
presence of chronic symptomatology and sometimes very disabling 
to lead a normal life, along with several previous misdiagnoses; (b) 
they emphasised above all the emotional impact during the diagnos-
tic process for them and their environment; (c) a significant change 
from the moment of diagnosis, ambivalent feelings but feeling of 
great psychological relief to be able to put a name to the disease; 
(iv) the need for patients and families to participate more actively in 
decision- making, as negative emotions sometimes act as a barrier; (v) 
the need for more support systems and they positively highlight the 
work of associations for those affected and their families; and finally 
(vi) the need for comprehensive and more humanistic care.
5  |  DISCUSSION
The findings of this study detailed the emotional reactions that 
emerged in the diagnostic process as a response to the challenges 
faced by the affected people and their families plus the support ele-
ments analysed in the form of facilitators or barriers. Not having a di-
agnosis and the delay in diagnosis were stressors identified in all the 
studies in this article and in the analysis of the interviews conducted. 
This absence and delay generates meaninglessness, which impacts 
the state of mental health of both patients and their families, requir-
ing psychosocial intervention (Kole & Faurisson, 2009).
Family caregivers felt responsible for managing the diagnostic 
process given the patient's health situation, leading the course of 
seeking the diagnosis, additional expertise and the need to make de-
cisions. All this generates feelings of guilt and high levels of anxiety 
(Applebaum et al., 2020). Guilt and helplessness were a way of being 
anchored in the past, making it difficult to focus on the present, 
blocking the possibility of accepting and adapting to the situation 
at hand. Similarly, high levels of anxiety and uncertainty hindered 
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the ability to think clearly and make decisions, concerns lead to pre-
dicting a future without having enough information to support this 
outlook, which could endanger vital goals and values in the face of 
loss of control and be a threat to self- concept (Zurynski et al., 2017).
Another of the outstanding findings of this study was the feel-
ing of confidence and security generated by having the diagnosis, 
apart from the uncertainty derived from the type of pathology. The 
diagnosis was valued as a turning point that allowed for adapta-
tion to a new normality (Germeni et al., 2018). It put an end to the 
process described by the presence of feelings of negative valence, 
whether they were high or low intensity, such as anger or deep 
sadness, respectively, which can lead patients and/or relatives to 
explode with aggressive behaviour and/or implode favouring the 
appearance of mood disorders such as depression (Morel & Cano, 
2017). Moreover, having a diagnosis also allowed the patient to feel 
acknowledged and accepted, as did the support of associations and 
people with the same pathology, which had repercussions on their 
self- concept and improved their self- esteem. But in newly diag-
nosed people, it could be a disadvantage as it may be distressing to 
show the seriousness of their illness (Keary et al., 2020). Although 
studies such as Ryu et al., (2020) report how having the diagnosis is 
a motivation to change habits, they refer to it as an opportunity to 
become a new me.
Patients report the sudden appearance of unusual symptoms, 
such as feeling a difference in their body or the anxiety impact of the 
arrival of an unknown disease with a strange name (Ryu et al., 2020). 
This impact is not only personal but also social, confronting the per-
son with a still challenging balance between equality and difference, 
and the search for a sense of normalcy (von der Lippe et al., 2017). 
This pattern of emotional responses prior to diagnosis could serve as 
a basis for developing psychological support tools for patients and 
families and for health professionals.
In the diagnostic process in general and in coherence with the 
results of this study, the importance of a health system and organ-
isational factors, such as communication and care coordination or 
large- scale national or international initiatives to improve healthcare 
delivery, should be emphasised (Singh et al., 2019), as well as es-
tablishing collaboration between healthcare providers, government, 
politicians and society to derive more resources and more adequate 
management (Shafie et al., 2020).
This review in line with other studies (Depping et al., 2021) 
showed that it is necessary to improve health systems since partic-
ipants had unmet psychological, social, personal, health and infor-
mation systems, and care needs. These psychological needs require 
the development of individual strategies like disease management 
strategies and emotion regulation strategies (Depping et al., 2021).
A basic aspect that stood out was the communication between a 
person with an RD, his or her family and professionals, as an essen-
tial element to maintain trust during the whole diagnostic process. 
The need for reciprocal communication to improve opportunities 
for collaboration and understanding is highlighted (McMullan et al., 
2020). The study by Gong et al. (2020) shows the differences in 
perception between doctors and patients, the former treating no 
more than one or two patients during their career, while the patients 
instead face the challenges of their illness for life. This element of 
perception must be overcome.
The potential of people with an RD as experts involved with 
training other people, caregivers or health professionals was another 
element that had emerged. In the study by McMullan et al. (2020) in 
addressing the training of professionals, they acknowledge the po-
tential for awareness that they can exercise and how patients can 
help professionals recognise the skills they already have that can be 
transferred to the care of a person with an RD. This patient experi-
ence also changes the traditional patient– doctor relationship, evolv-
ing into a pattern of patient- led interaction (Budych et al., 2012). The 
patient is an active force for change.
In line with the Granero- Molina et al. (2020) included in this re-
view, the nurse practitioner is key to restructuring service delivery 
as he or she can ensure the removal of some barriers and encourage 
communication to provide accessible and affordable care to an RD 
patient (Allred et al., 2017). The nurse practitioner can play a crucial 
role in coordinating communication between patients, their families 
and all healthcare providers on the team. However, as with other 
healthcare professionals, it is essential to improve the level of train-
ing. Walkowiak and Domaradzki (2020) study of nursing students 
and professionals highlights the need for specific training and details 
important shortcomings. Given the genetic origin of many RDs, it is 
essential to pay attention to precision medicine and health care, the 
integration of genetic and genomic knowledge as an essential com-
petency in nursing care, research and education (Lebet et al., 2019).
Requena et al., (2014) state that emotional stress was almost in-
evitable in the communication of the diagnosis. Patients narrated this 
moment as traumatic. The scarce knowledge of the diagnosis affected 
even the professionals, materialising in the use of terminology or tech-
nicalities never previously heard by the patient or family. Therefore, 
it is essential that professionals have guidelines and resources that 
can help these newly diagnosed individuals with an RD acquire appro-
priate coping strategies (Allred et al., 2017; Morel & Cano, 2017). As 
described above, professionals have a significant influence on the ex-
periences and perceptions of patients and/or their families and can be 
a support or an obstacle for them (Walkowiak & Domaradzki, 2020).
Nursing plays an essential role, and they are always at the pa-
tient's side, accompanying them to improve their quality of life. RDs 
require clear guidelines for action, and training for nurses is neces-
sary, as there are more than 7,000 RD characterised by a wide diver-
sity of symptoms that can vary not only from disease to disease but 
also from patient to patient suffering from the same disease. Training 
on RD should be included in the curricula of Nursing Universities, as 
this would have a very positive impact on both the affected patient 
and their relatives (Walkowiak & Domaradzki, 2020).
The training of future professionals in the field of rare diseases is 
very important; nurses trained in the care process are needed to pro-
vide comprehensive care. The corresponding care must be provided 
in each case, taking into account the specificities of each disease and 
of the person him/herself at each moment. Having the opportunity 
to learn about cases of different RD gives us a much broader field of 
vision of the characteristics, course of the pathology, evolution and 
nursing needs in each one of them (Walkowiak & Domaradzki, 2020).
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5.1  |  Limitations
The main limitation is the heterogeneity of the studies in relation 
to the inclusion of all possible RDs. By performing a global search 
rather than exploring by disease, some relevant studies may have 
been excluded in the process. Moreover, by focusing only on the 
pre- diagnostic phase and the phase at the time of diagnosis, some 
articles may have been lost due to the difficulty of obtaining this 
information. In addition, the included studies were conducted in 
different countries and the patients’ health conditions and cul-
tural backgrounds could be different. But most of the studies 
were within Western culture, mainly in Europe, North America and 
Australia. In contrast, very little has been studied in poor coun-
tries. The reason being that in those countries, neither diagnosis 
nor treatment can be aspired to by most people affected by RDs. 
Besides, there is a lack of awareness of its importance, which is 
the first step in defining health, diagnostic and treatment policies 
(Agrawal et al., 2019).
5.2  |  Implications for practice, 
education or research
This study revealed the need for health policy makers to contem-
plate the biopsychosocial impact of pre- diagnosis and timing of diag-
nosis, considering that individuals with an RD and their families are 
more vulnerable. That is why professionals need formative, informa-
tive and technological support systems.
Similarly, with the results obtained, it is suggested that a network 
of expert nurses should be developed to help alleviate the pressure 
on patients and families. The nurse can play a fundamental role as a 
case manager, being a link between professionals, and solving basic 
care needs of patients. The nurse with her/his assignment of pre-
vention and health promotion is fundamental in the development 
of the autonomy of the affected persons, carrying out specific in-
terventions that promote self- care, maintenance of daily activities, 
readaptation to the environment and/or emotional support.
As this article shows, the emotional consequences of the diag-
nostic process require emotional support for people affected by RD. 
This is an essential pillar of treatment. The nurse is trained to help 
people to manage the emotional impact to favour their adaptation 
and to avoid psychopathological consequences, and when it is not 
possible to deal with it due to the level of nursing competence, to 
refer them to other professionals. There is also a need to develop 
transdisciplinary work between health and social professionals.
Training in RD should be included in nursing education curricula, 
not only from the description of these processes but also from the 
detection of needs that can improve the quality of life of patients. 
Its incorporation would also help to raise visibility and awareness 
of these diseases through nurses. It is expected that this study will 
promote other research to respond to the problems identified in two 
aspects: one related to the development of biopsychosocial coping 
strategies and the other related to improving the interventions of 
nursing. In addition, more future studies are needed to include more 
patients and diversity of RDs.
6  |  CONCLUSIONS
This study provides evidence of the impact of the diagnostic process 
on people affected by an RD and their family members, and of the 
support systems in the form of facilitators and barriers. This should 
enable a more precise and adapted approach and provide tools for 
improvement of health systems and professionals in the form of in-
formation, training and resources (local, national and international). 
The harmonisation of global strategies should minimise the impact 
of socio- demographic inequalities.
Studies show the potential of affected people and their families 
as a key element of adaptation and normalisation. Those affected 
ask professionals to develop non- technical skills, used in all types of 
diseases, such as confidence building, communication, coordination 
and a comprehensive approach to professionals. In this context, the 
nursing professional can play a key role in coordinating communi-
cation between those affected, their families and all the healthcare 
and social care providers in the health team and develop diagnostic 
support tools. Finally, it would be important to increase research in 
relation to the diagnostic process to provide professionals and af-
fected people and their families with more knowledge.
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